NCT02354352
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
See it on ClinicalTrials.gov ↗52 people
100%
0 womenmiddle line = equal numbers52 men
- Phase
- PHASE3
- Paid for by
- Ohio State University
- Finished
- 2018-05
- Health conditions
- Duchenne Muscular Dystrophy
- Who could join
- Men only
- Ages
- 7 Years – no maximum
- Average age
- median 14 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 94.2% · Black / African American 3.8% · More than one race 1.9% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · Not reported 0%
Women left out
- Men only
No women were allowed to join.
“Eligibility: Male participants only.”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Kidney disease”
Study titles and rules are shown in their original English.